Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging
Open Access
- 1 September 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 179 (9) , 1230-1239
Abstract
Recently, the US Food and Drug Administration proposed updating the Mammography Quality Standards Act of 1992 to require that mammography reports provided to health care professionals and women incorporate information regarding a woman’s breast density.1 Thirty-six states already require some level of notification on screening mammography reports of breast density,2 a radiologic term that describes the proportion of parenchymal relative to fatty tissue in mammograms. Fifteen states advise women to discuss the possible benefits of supplemental imaging with their practitioners, which has been associated with increased supplemental ultrasonography use.3 Supplemental screening for breast cancer may benefit women who have been notified that they have dense (heterogeneously or extremely dense) breasts and who are at increased risk of interval and advanced breast cancer.4 The American College of Radiology suggests that supplemental ultrasonography may be useful for incremental cancer detection in women with dense breasts as the only risk factor.5 The US Preventive Services Task Force found insufficient evidence to assess the balance of benefits and harms of supplemental screening in women with dense breasts.6Keywords
This publication has 44 references indexed in Scilit:
- Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone TherapyJAMA Internal Medicine, 2013
- Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy UseJournal of Clinical Oncology, 2010
- Longitudinal Measurement of Clinical Mammographic Breast Density to Improve Estimation of Breast Cancer RiskJNCI: Journal of the National Cancer Institute, 2007
- Marginal Modeling of Nonnested Multilevel Data using Standard SoftwareAmerican Journal of Epidemiology, 2006
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Marginal modeling of multilevel binary data with time-varying covariatesBiostatistics, 2004
- Marginal modeling of multilevel binary data with time-varying covariatesBiostatistics, 2004
- Women’s Views on Breast Cancer Risk and Screening MammographyMedical Decision Making, 2001
- Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.American Journal of Roentgenology, 1997
- Radiological protection and safety in medicineAnnals of the ICRP, 1996